# Chemoprevention Therapy Plus Surgery in Treating Women With Breast Cancer

> **NCT00003099** · PHASE2 · COMPLETED · sponsor: **M.D. Anderson Cancer Center** · enrollment: 52 (actual)

## Conditions studied

- Breast Cancer

## Interventions

- **DRUG:** Fenretinide
- **DRUG:** Tamoxifen Citrate
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT00003099
- **Lead sponsor:** M.D. Anderson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1996-05
- **Primary completion:** 2000-06
- **Final completion:** 2003-01
- **Target enrollment:** 52 (ACTUAL)
- **Last updated:** 2012-07-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00003099

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00003099, "Chemoprevention Therapy Plus Surgery in Treating Women With Breast Cancer". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00003099. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*